The insulin-like growth factor i receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor

Journal of Experimental Medicine

Volumn 175, Issue 4, 1992, Pages 1081-1090

  Krane, Jeffrey F ^a   Gottlieb, Alice B ^a   Carter, Martin ^a   Krueger, James G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM IONOPHORE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; PHORBOL ESTER; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; FETUS; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KERATINOCYTE; LIGAND BINDING; NEWBORN; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY;

ANTIBODIES, MONOCLONAL; CALCIMYCIN; EPIDERMAL GROWTH FACTOR; EPIDERMIS; HUMAN; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; PRECIPITIN TESTS; PROTEIN KINASES; PSORIASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; RECEPTORS, SOMATOMEDIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE;

EID: 0026555610     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.175.4.1081     Document Type: Article

References (32)

1. Daughaday, W.H., and P. Rotwein. 1989. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev.10:68.
2. Massague, J., and M.P. Czech. 1982. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J. Biol. Chem. 257:5038.
3. Czech, M.P. 1989. Signal transmission by the insulin-like growth factors. Cell.59:235.
4. Ullrich, A., A. Gray, A.W. Tàm, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kathuria, E. Chen, S. Jacobs, U. Francke, J. Ramachandran, and Y. Fujita-Yamaguchi. 1986. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO (Eur. Mol. Biol. Organ.) J.5:2503.
5. Lammers, R., A. Gray, J. Schlessinger, and A. Ullrich. 1989. Differential signalling potential of insulin- and IGF-l-receptor cytoplasmic domains. EMBO (Eur. Mol. Biol. Organ.) J.8:1369.
6. Werner, H., M. Woloschak, M. Adamo, Z. Shen-Orr, C.T. Roberts, Jr., and D. LeRoith. 1989. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA.86:7451.
7. Misra, P., B.J. Nickoloff, V.B. Morhenn, R.L. Hintz, and R.G. Rosenfeld. 1986. Characterization of insulin-like growth factor-I/somatomedin-C receptors on human keratinocyte monolayers. J. Invest. Dermatol.87:264.
8. Nickoloff, B.J., P. Misra, V.B. Morhenn, R.L. Hintz, and R.G. Rosenfeld. 1988. Further characterization of the keratinocyte somatomedin-C/insulin-like growth factor I (SM-C/IGF-1) receptor and the biological responsiveness of cultured kératinocytes to SM-C/IGF-1. Dermatologica (Basel).177:265.
9. Krane, J.F., D.P. Murphy, D.M. Carter, and J.G. Krueger. 1991. Synergistic effects of epidermal growth factor (EGF) and insulinlike growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J. Invest. Dermatol.96:419.
10. Pfeifle, B., and H. Ditschuneit. 1983. Two separate receptors for insulin and insulin-like growth factors on arterial smooth muscle cells. Exp. Clin. Endocrinol.81:280.
11. Rosenfeld, R.G., and L.A. Dollar. 1982. Characterization of the somatomedin-C/insulin-like growth factor I (SM-C/IGF I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF I and insulin. J. Clin. Endocrinol. & Metab55:434.
12. Pardee, A.B. 1989. Gi events and regulation of cell proliferation. Science (Wash. DC).246:603.
13. Ristow, H.-J., and T.O. Messmer. 1988. Basic fibroblast growth factor and insulin-like growth factor I are strong mitogens for cultured mouse keratinocytes. J. Cell. Physiol137:277.
14. 125I]epidermal growth factor binding and receptor distribution in psoriasis.Invest. Dermatol.86:260.
15. Green, M.R., and J.R. Couchman. 1985. Differences in human skin between the epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition. J. Invest. Dermatol.85:239.
16. Kull, F.C., Jr., S. Jacobs, Y.-F. Su, M.E. Svoboda, J.J. Van Wyk, and P. Cuatrecassas. 1983. Monoclonal antibodies to receptors for insulin and somatomedin-C. J. Biol. Chem.258:6561.
17. Jacobs, S., S. Cook, M.E. Svoboda, and J.J. Van Wyk. 1986. Interaction of the monoclonal antibodies a-IR-1 and a-IR-3 with insulin and somatomedin-. receptors Endocrinology.118:223.
18. Catanese, V.M., F. Grigorescu, G.L. King, and R.C. Kahn. 1986. The human erythrocyte insulin-like growth factor I receptor: characterization and de monstration of ligand-stimulated autophosphorylation.Clin. Endocrinol. & Me tab. 62:692.
19. Furlanetto, R.W., J.N. DiCarlo, and C. Wisehart. 1987. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J. Clin. Endocrinol. & Metab.64:1142.
20. Aaronson, S.A., J.S. Rubin, P.W. Finch, J. Wong, C. Mar-chese, J. Falco, W.G. Taylor, and M.H. Kraus. 1990. Growth factor-required pathways in epithelial cell proliferation. Am. Rev. Respir. Dis.142:S7.
21. Van Scott, E.J., and T.M. Ekel. 1963. Kinetics of hyperplasia in psoriasis. Arch. Dermatol.88:373.
22. Davis, R.J. 1988. Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity. J. Biol Chem.263:9462.
23. Liu, C., and T.E. Hermann. 1978. Characterization of iono-mycin as a calcium ionophore. J. Biol. Chem.253:5982.
24. Werner, H., B. Stannard, M.A. Bach, D. LeRoith, and C.T. Roberts. 1990. Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene. Biochem. Biophys. Res. Commun.169:1021.
25. Gottlieb, A.B., C.K. Chang, D.N. Posnett, B. Fanelli, andJ.P. Tam. 1988. Detection of transforming growth factor (S in normal, malignant, and hyperproliferative human kératinocytes. J. Exp Med.167:670.
26. Elder, J.T., G.J. Fisher, P.B. Lindquist, G.L. Bennett, M.R. Pittelkow, R.J. Coffey, Jr., L. Ellingsworth, R. Derynck, and J.J. Voorhees. 1989. Overexpression of transforming growth factor a in psoriatic epidermis. Science (Wash. DC).243:811.
27. Stewart, A.J., M.D. Johnson, F.E.B. May, and B.R. Westley. 1990. Role of insulin-like growth factors and the type I insulinlike growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem.265:21172.
28. Braverman, I.M., and A. Yen. 1977. Ultrastructure of the human dermal microcirculation: II. The capillary loops of the dermal papillae. J. Invest. Dermatol.68:44.
29. Krane, J.F., D.P. Murphy, A.B. Gottlieb, D.M. Carter, C.E. Hart, and J.G. Krueger. 1991. Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis. J. Invest. Dermatol.96:983.
30. Hansson, H.-A., R. Jonsson, and K. Petruson. 1988. Transiently increased insulin-like growth factor I immunoreactivity in UVB-irradiated mouse skin. J. Invest. Dermatol.91:328.
31. Camisa, C. 1989. Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology. Arch. Dermatol. 125:407.
32. Gentleman, S., T.A. Martensen, J.J. Digiovanna, and G.J. Chader. 1984. Protein tyrosine kinase and protein phosphotyro-sine phosphatase in normal and psoriatic skin. Biochim. Biophys. Acta.798:53.